FDA Announces Collection of Information for OMB Review

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, as required by the Paperwork Reduction Act of 1995, in an effort to permanently discontinue or interrupt the manufacturing of certain drug and biological products.